Pregabalin modulation of neurotransmitter release is mediated by change in intrinsic activation/inactivation properties of Cav2.1 calcium channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 336, Issue 3, 2011, Pages 973-982

  Di Guilmi, Mariano N ^a   Urbano, Francisco J ^a   Inchauspe, Carlota Gonzalez ^a   Uchitel, Osvaldo D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL CAV2.1; LIDOCAINE ETHOBROMIDE; PREGABALIN; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

AMPLITUDE MODULATION; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CALCIUM CURRENT; CHANNEL GATING; CONTROLLED STUDY; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; DOSE RESPONSE; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; MOUSE; NERVE CELL; NEUROMODULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; CALCIUM CHANNELS, N-TYPE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY POSTSYNAPTIC POTENTIALS; GAMMA-AMINOBUTYRIC ACID; MICE; NEUROTRANSMITTER AGENTS;

EID: 79951975913     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.172171     Document Type: Article

References (40)

1. Bayer K, Ahmadi S, and Zeilhofer HU (2004) Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channels. Neuropharmacology 46:743-749. (Pubitemid 38292979)
2. Belliotti TR, Capiris T, Ekhato IV, Kinsora JJ, Field MJ, Heffner TG, Meltzer LT, Schwarz JB, Taylor CP, Thorpe AJ, et al. (2005) Structure-activity relationships of pregabalin and analogues that target the α2-δ protein. J Med Chem 48:2294-2307. (Pubitemid 40516424)
3. Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA, and Pregabalin 1008-009 Study Group (2005) Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64:475-480.
4. Blake MG, Boccia MM, Acosta GB, Höcht C, and Baratti CM (2007) Opposite effects of a single versus repeated doses of gabapentin on retention performance of an inhibitory avoidance response in mice. Neurobiol Learn Mem 87:192-200. (Pubitemid 46038947)
5. Borst JG and Sakmann B (1998) Facilitation of presynaptic calcium currents in the rat brainstem. J Physiol 513 (Pt 1):149-155. (Pubitemid 28528573)
6. 4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci 8:1752-1759.
7. Burgess DL and Noebels JL (1999) Voltage-dependent calcium channel mutations in neurological disease. Ann NY Acad Sci 868:199-212. (Pubitemid 29281126)
8. Cunningham MO, Woodhall GL, Thompson SE, Dooley DJ, and Jones RS (2004) Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro. Eur J Neurosci 20:1566-1576. (Pubitemid 39294695)
9. Cuttle MF, Tsujimoto T, Forsythe ID, and Takahashi T (1998) Facilitation of the presynaptic calcium current at an auditory synapse in rat brainstem. J Physiol 512 (Pt 3):723-729. (Pubitemid 28505303)
10. Eroglu C, Allen NJ, Susman MW, O'Rourke NA, Park CY, Ozkan E, Chakraborty C, Mulinyawe SB, Annis DS, Huberman AD, et al. (2009) Gabapentin receptor α2δ-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 139:380-392.
11. Fedchyshyn MJ and Wang LY (2005) Developmental transformation of the release modality at the calyx of Held synapse. J Neurosci 25:4131-4140. (Pubitemid 40563389)
12. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD Jr, Hawkes R, Frankel WN, Copeland NG, and Jenkins NA (1996) Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87:607-617. (Pubitemid 26386935)
13. 2δ subunit of a calcium channel. J Biol Chem 271:5768-5776.
14. 2δ ligand gabapentin. Proc Natl Acad Sci USA 105:3628-3633.
15. Hori T and Takahashi T (2009) Mechanisms underlying short-term modulation of transmitter release by presynaptic depolarization. J Physiol 587:2987-3000.
16. Inchauspe CG, Martini FJ, Forsythe ID, and Uchitel OD (2004) Functional compensation of P/Q by N-type channels blocks short-term plasticity at the calyx of held presynaptic terminal. J Neurosci 24:10379-10383. (Pubitemid 39552622)
17. Iwasaki S and Takahashi T (1998) Developmental changes in calcium channel types mediating synaptic transmission in rat auditory brainstem. J Physiol 509 (Pt 2):419-423. (Pubitemid 28287000)
18. Johannessen SI, Battino D, Berry DJ, Bialer M, Krämer G, Tomson T, and Patsalos PN (2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25:347-363. (Pubitemid 36638181)
19. 2δ subunit reduces neurotransmission in mice. Eur J Pharmacol 553:82-88.
20. 2δ subunits: differential expression, function, and drug binding. J Bioenerg Biomembr 35:639-647.
21. Maneuf YP, Gonzalez MI, Sutton KS, Chung FZ, Pinnock RD, and Lee K (2003) Cellular and molecular action of the putative GABA-mimetic, gabapentin. Cell Mol Life Sci 60:742-750. (Pubitemid 36570764)
22. 2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. Neuropharmacology 42:353-366.
23. Masdrakis VG, Oulis P, Karakatsanis NA, Potagas C, Kouzoupis AV, and Soldatos CR (2008) Remission of migraine attacks in a patient with depression who is taking pregabalin. Clin Neuropharmacol 31:238-240.
24. McClelland D, Evans RM, Barkworth L, Martin DJ, and Scott RH (2004) A study comparing the actions of gabapentin and pregabalin on the electrophysiological properties of cultured DRG neurones from neonatal rats. BMC Pharmacol 4:14.
25. Micheva KD, Taylor CP, and Smith SJ (2006) Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons. Mol Pharmacol 70:467-476. (Pubitemid 44092307)
26. Noebels JL (2001) Modeling human epilepsies in mice. Epilepsia 42 (Suppl 5):11-15.
27. Patil PG, Brody DL, and Yue DT (1998) Preferential closed-state inactivation of neuronal calcium channels. Neuron 20:1027-1038. (Pubitemid 28247407)
28. Pietrobon D (2005) Function and dysfunction of synaptic calcium channels: insights from mouse models. Curr Opin Neurobiol 15:257-265.
29. 2δ -subunit. Am J Physiol 274:C1324-C1331.
30. Schneggenburger R and Forsythe ID (2006) The calyx of Held. Cell Tissue Res 326:311-337. (Pubitemid 44444792)
31. Stefani A, Spadoni F, and Bernardi G (1998) Gabapentin inhibits calcium currents in isolated rat brain neurons. Neuropharmacology 37:83-91. (Pubitemid 28300140)
32. Stewart BH, Kugler AR, Thompson PR, and Bockbrader HN (1993) A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharm Res 10:276-281. (Pubitemid 23041744)
33. Su TZ, Feng MR, and Weber ML (2005) Mediation of highly concentrative uptake of pregabalin by L-type amino acid transport in Chinese hamster ovary and Caco-2 cells. J Pharmacol Exp Ther 313:1406-1415. (Pubitemid 40727048)
34. Sutton KG, Martin DJ, Pinnock RD, Lee K, and Scott RH (2002) Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 135:257-265. (Pubitemid 34102120)
35. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, Dooley DJ, Boden P, and Singh L (1998) A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 29:233-249. (Pubitemid 28137601)
36. 2δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73:137-150.
37. 2-δ] ligands. Pain 142:13-16.
38. Taylor CP and Garrido R (2008) Immunostaining of rat brain, spinal cord, sensory neurons and skeletal muscle for calcium channel alpha2-delta (α2δ) type 1 protein. Neuroscience 155:510-521.
39. Terwindt GM, Ophoff RA, Lindhout D, Haan J, Halley DJ, Sandkuijl LA, Brouwer OF, Frants RR, and Ferrari MD (1997) Partial cosegregation of familial hemiplegic migraine and a benign familial infantile epileptic syndrome. Epilepsia 38:915-921. (Pubitemid 27323601)
40. Welch KM (2005) Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention. Headache 45 (Suppl 1):S25-S32.